Gallium-68-labeled fibroblast activation protein inhibitor-46 PET in patients with resectable or borderline resectable pancreatic ductal adenocarcinoma: A phase 2, multicenter, single arm, open label non-randomized study protocol
oleh: Aashna Karbhari, Sherly Mosessian, Kamaxi H. Trivedi, Frank Valla, Mark Jacobson, Mark J. Truty, Nandakumar G. Patnam, Diane M. Simeone, Elcin Zan, Tracy Brennan, Hongli Chen, Phillip H. Kuo, Ken Herrmann, Ajit H. Goenka
| Format: | Article |
|---|---|
| Diterbitkan: | Public Library of Science (PLoS) 2023-01-01 |
Deskripsi
No description available for this item.